Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
収録刊行物
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 16 (9), 1533-1546, 2021-09
Elsevier BV